EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER
TCTMD
Online Media
New York, NY 596 followers
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions.
About us
TCTMD is the most comprehensive on-line resource in interventional cardiology and provides in-depth coverage of the percutaneous treatment of cardiovascular disease. TCTMD is produced and administered by the Cardiovascular Research Foundation (CRF). Subscription to TCTMD is free through completion of a registration form found at www.tctmd.com/register.aspx.
- Website
-
https://tctmd.com/
External link for TCTMD
- Industry
- Online Media
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Nonprofit
Locations
-
Primary
1700 Broadway
New York, NY 10019, US
Employees at TCTMD
-
Caitlin E. Cox
Medical Editor/Writer
-
Navjot Kaur Sobti, M.D.
Interventional Cardiologist, Educator & Medical Journalist • NYU Grossman School of Medicine •
-
Omar Shazly
MD' 24 | First Generation Medical Doctor | ECFMG Certified
-
Tehreem Fatima
MS5 I KEMU I USMLE Step 1 ✅I Ambassador @Amboss| Aspiring intervention cardiologist
Updates
-
Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits
Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits
tctmd.com
-
ICYMI: Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial
Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial
tctmd.com
-
Heart Valve Matters Episode 3: RESHAPE-HF2
Heart Valve Matters Episode 3: RESHAPE-HF2
tctmd.com
-
‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF
‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF
tctmd.com
-
‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM
‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM
tctmd.com
-
How do different COVID-19 vaccine doses impact cardiovascular safety? In this week's #QuickTakes, Venexia Walker shares the results indicating fewer CV events. Watch the full video here: https://lnkd.in/eAGF_Vy2
-
FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades
FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades
tctmd.com
-
Check out the most popular TCTMD stories from September in this month's newsletter! Highlighting stories that feature: Bhavanadhar Penta, Obadia Jean-Francois, Aakriti Gupta, MD MSc, Piotr Ponikowski, Harlan Krumholz, Nathan Mewton, John William (Bill) McEvoy, Joseph Ebinger, Scott Solomon, Pardeep Jhund, Rishi Puri, Simon Redwood, Rodrigo Bagur, Professor Vijay Kunadian, Mirvat Alasnag, Massimo Baudo, Bobby Yanagawa, Rajdip Dulai, Nazem Akoum, Stylianos Tzeis, Volker Rudolph, Jo Chikwe, Stephan Baldus, David Messika-Zeitoun, Valgimigli Marco, and more!
TCTMD’s Top 10 Most Popular Stories for September 2024
TCTMD on LinkedIn
-
The ILUMIEN IV Trial
The ILUMIEN IV Trial